Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes

Summary

This is a randomized, double-blind, active-controlled, phase III clinical trial to investigate the efficacy and safety of evogliptin when added to ongoing metformin monotherapy in patients with type 2 diabetes who have inadequate glycemic control

Timeline

Start

2013-05

Primary completion

2014-11

Completion

2015-05

Drugs

Indications